884 results on '"Seiler, Roland"'
Search Results
2. Bladder cancer organoids as a functional system to model different disease stages and therapy response
3. Guidance of adjuvant instillation in intermediate-risk non-muscle invasive bladder cancer by drug screens in patient derived organoids: a single center, open-label, phase II trial
4. Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis
5. Uroplakin II as a single marker for luminal versus basal molecular subtypes in muscle invasive urothelial carcinoma
6. Systematic Review of Factors Associated with the Utilization of Radical Cystectomy for Bladder Cancer
7. Prognostic Role of RNA Expression Molecular Biomarkers in Prostate and Bladder Cancers
8. Receptor Activator of NF Kappa B (RANK) Expression Indicates Favorable Prognosis in Patients with Muscle-invasive Bladder Cancer
9. Intentionen und Intentionstraining im Sport
10. Anxiety and Volleyball Performance in a Real Testing Situation: Gender Differences in Competitive Environments
11. Predictive models of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer using nuclear morphology and tissue architecture
12. Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case Report
13. Postoperative Chemotherapy Bladder Instillation After Radical Nephroureterectomy: Results of a European Survey from the Young Academic Urologist Urothelial Cancer Group
14. Urothelial Carcinoma in Bladder Diverticula: A Multicenter Analysis of Characteristics and Clinical Outcomes
15. Key players in sport teams. An exploratory study on the effects of attachment styles on intra-team relational networks
16. BCG for the Treatment of Non-muscle Invasive Bladder Cancer
17. The association of cigarette smoking and pathological response to neoadjuvant platinum-based chemotherapy in patients undergoing treatment for urinary bladder cancer - A prospective European multicenter observational study of the EAU Young Academic Urologists (YAU) urothelial carcinoma working group
18. Diagnostic Value of Urine Cytology in Pharmacologically Forced Diuresis for Diagnosis and Follow-Up of Upper Tract Urothelial Carcinoma
19. Bladder cancer cells secrete while normal bladder cells express but do not secrete AGR2
20. A showcase study on personalized in silico drug response prediction based on the genetic landscape of muscle invasive bladder cancer
21. Discrepancy Between European Association of Urology Guidelines and Daily Practice in the Management of Non–muscle-invasive Bladder Cancer: Results of a European Survey
22. Diagnostic Value of Urine Cytology in Pharmacologically Forced Diuresis for Upper Tract Urothelial Carcinoma Diagnosis and Follow-Up.
23. Guiding adjuvant instillation in intermediate-risk non-muscle invasive bladder cancer by drug screens in patient-derived organoids.
24. Achieving teamwork in naturalistic sport settings: An exploratory qualitative study of informational resources supporting football players' activity when coordinating with others
25. Do the effects of nonverbal behaviour on team outcome confidence in team sports depend on the availability of additional performance information?
26. Forty years of cisplatin-based chemotherapy in muscle-invasive bladder cancer: are we understanding how, who and when?
27. Outplaying opponents—a differential perspective on passes using position data
28. Update of the ICUD–SIU International Consultation on Bladder Cancer 2018: urinary diversion
29. Corrigendum to “Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer” [Eur Urol 2023;83:313–17]
30. BCG for the Treatment of Non-muscle Invasive Bladder Cancer
31. Correction to: Genomic Subtyping in Bladder Cancer
32. Genomic Subtyping in Bladder Cancer
33. Intentionen und Intentionstraining im Sport
34. List of Contributors
35. Multicenter Validation of Histopathologic Tumor Regression Grade After Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma
36. Unravelling disparate roles of NOTCH in bladder cancer
37. Figure S1 from Paternally Expressed Gene 10 (PEG10) Promotes Growth, Invasion, and Survival of Bladder Cancer
38. Data from Selective Inhibition of the Lactate Transporter MCT4 Reduces Growth of Invasive Bladder Cancer
39. Supplementary Data from Selective Inhibition of the Lactate Transporter MCT4 Reduces Growth of Invasive Bladder Cancer
40. Supplementary Information from Paternally Expressed Gene 10 (PEG10) Promotes Growth, Invasion, and Survival of Bladder Cancer
41. Supplementary Table S1 from Paternally Expressed Gene 10 (PEG10) Promotes Growth, Invasion, and Survival of Bladder Cancer
42. SupplementaryTable S2 from Paternally Expressed Gene 10 (PEG10) Promotes Growth, Invasion, and Survival of Bladder Cancer
43. Data from Paternally Expressed Gene 10 (PEG10) Promotes Growth, Invasion, and Survival of Bladder Cancer
44. Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer
45. PD25-07 PROTEOMIC PROFILING OF MUSCLE INVASIVE BLADDER CANCER TREATED WITH NEOADJUVANT CHEMOTHERAPY REVEALS UNIQUE BIOLOGIC CLUSTERS WITH CLINICAL RELEVANCE
46. Supplementary Data from Molecular Characterization of Neuroendocrine-like Bladder Cancer
47. Data from Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer
48. Supplementary Data from Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer
49. Supplementary Figures from Molecular Characterization of Neuroendocrine-like Bladder Cancer
50. Which Patients To Consider for Bladder Preservation After a Complete Response to Neoadjuvant Chemotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.